|Year : 2020 | Volume
| Issue : 2 | Page : 177-181
Efficacy of 0.5 mg/kg of propofol at the end of anesthesia to reduce the incidence of emergence agitation in children undergoing general anesthesia with sevoflurane
Andi Ade Wijaya Ramlan, Dimas K. Bonardo Pardede, Arif H. M. S Marsaban, Jefferson Hidayat, Fildza Sasri Peddyandhari
Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
|Date of Submission||08-Aug-2019|
|Date of Acceptance||10-Nov-2019|
|Date of Web Publication||15-Jun-2020|
Dr. Andi Ade Wijaya Ramlan
Departemen Anestesiologi dan Terapi Intensif, Jl Diponegoro No. 71, Jakarta Pusat, DKI Jakarta - 10430
Source of Support: None, Conflict of Interest: None
Background and Aims: Emergence agitation (EA) is a common transient behavioral disturbance after inhalational anesthesia and may cause harm to the patient. This study evaluated the efficacy of 0.5 mg/kg of propofol administered at the end of anesthesia to reduce the incidence of EA in children undergoing general inhalational anesthesia.
Material and Methods: This double-blind randomized clinical trial was done in children aged 1–5 years undergoing general anesthesia with sevoflurane. One hundred and eight subjects were included using consecutive sampling method and randomized into two equal groups. Propofol in the dose of 0.5 mg/kg was administered at the end of anesthesia to children in the propofol group, while those in the control group did not receive any intervention at the end of anesthesia. Incidence of EA, transfer time, postoperative hypotension, desaturation, and nausea-vomiting were observed. Aono and Pediatric Anesthesia Emergence Delirium scale were used to assess EA.
Results: Incidence of EA was 25.9% in the propofol group compared to 51.9% in the control group (RR = 0.500; 95% CI 0.298–0.840; P = 0.006). Mean transfer time in propofol group was longer (9.5 ± 3.9 min) than control group (7.8 ± 3.6 min) (mean difference 1.71 min; 95% CI 0.28–3.14; P = 0.020). Hypotension was found in one patient (1.9%) in propofol group, while in control group there was none. Nausea-vomiting was found in five patients (9.3%) in propofol group and eight patients (14.8%) in control. There was no desaturation in both the groups.
Conclusion: Administration of 0.5 mg/kg of propofol at the end of anesthesia effectively reduces the incidence of EA in children undergoing general inhalational anesthesia with sevoflurane.
Keywords: Agitation, children, delirium, emergence, propofol, sevoflurane
|How to cite this article:|
Ramlan AA, Pardede DK, Marsaban AH, Hidayat J, Peddyandhari FS. Efficacy of 0.5 mg/kg of propofol at the end of anesthesia to reduce the incidence of emergence agitation in children undergoing general anesthesia with sevoflurane. J Anaesthesiol Clin Pharmacol 2020;36:177-81
|How to cite this URL:|
Ramlan AA, Pardede DK, Marsaban AH, Hidayat J, Peddyandhari FS. Efficacy of 0.5 mg/kg of propofol at the end of anesthesia to reduce the incidence of emergence agitation in children undergoing general anesthesia with sevoflurane. J Anaesthesiol Clin Pharmacol [serial online] 2020 [cited 2021 Jul 26];36:177-81. Available from: https://www.joacp.org/text.asp?2020/36/2/177/286777
| Introduction|| |
Sevoflurane is an inhalation anesthetic agent commonly used for pediatric patients; however, it is associated with a high incidence of emergence agitation (EA) in the postoperative period. EA is a postoperative behavior disorder marked by a temporary excitation period during the recovery phase of anesthesia. The incidence of EA varies around 10% to 80%, with the highest incidence found in patients aged 2 to 5 years., A previous study by Aktara showed that the incidence of EA in our population was 39.7%. Although it is a temporary and self-limiting condition, EA potentially endangers patients and threatens patient safety. Many studies have been performed to reveal possible causes, prevention, and treatment of EA, but no definite guidelines have been established.
Propofol is a hypnotic amnestic agent with a short duration of action, commonly used for sedation, induction, and maintaining anesthesia. Studies show that administration of intravenous (IV) propofol 1–3 mg/kg at the end of inhalation anesthesia may reduce the incidence of EA. However, it is also associated with a prolonged time for extubation, time to transport to the Postanesthesia Care Unit (PACU), and return to consciousness, hence hindering the readiness of patient turnover in the operating room.,, There is a paucity of the literature on the effectiveness of doses less than 1 mg/kg of propofol given at the end of inhalation anesthesia to decrease the incidence of EA. We expected that a smaller dose of propofol would not prolong the patient's tracheal extubation time. This study aimed to determine the efficacy of 0.5 mg/kg of propofol given at the end of inhalation anesthesia in reducing-the incidence of postoperative EA after general anesthesia with sevoflurane.
| Material and Methods|| |
This randomized double-blinded clinical trial was conducted after approval from the Ethics Committee of the Institution on 108 physical status ASA 1 or 2 children aged 1 to 5 years, undergoing surgical procedure under general anesthesia using sevoflurane. The sample size was calculated using unpaired categorical comparative analytic tests, with an expected clinical difference of 20%, power of 84%, baseline incidence of EA of 40%, and an alpha error of 5%. Hence, the calculated sample size was 108. Accessible population during the study period included 266 children. Twenty-four subjects did not fulfill inclusion criteria, while 134 subjects were excluded. The parents or caregiver of the patients gave written consent. Exclusion criteria were as follows: emergency surgery, ophthalmologic procedures, adenotonsillectomy, ICU admission with mechanical ventilation, psychology or neurologic deficits, delayed growth and development, sedative drugs therapy, history of allergy to propofol, susceptible for malignant hyperthermia, predicted difficult airway, cardiovascular disorders that affects physical status, and hemodynamic instability. A drop out criterion was the occurrence of perioperative emergency and the unplanned need for postoperative care in the ICU with mechanical ventilation.
Randomization was performed in the preparation room with the help of www.randomizer.org. The results of the randomization were put in a sealed numbered envelope to a third-party responsible for the anesthesia without involvement of the research team. After premedication with 0.5 mg/kg of ketamine intravenously, patients were taken into the operating room, standard monitoring devices such as pulse oximetry, electrocardiogram, and non-invasive blood pressure (NIBP) were placed. Pediatric anesthesia behavior score was recorded for each patient during the induction of anesthesia. Anesthesia was induced with sevoflurane, and atracurium was used to facilitate endotracheal intubation or laryngeal mask airway (LMA) insertion. Sevoflurane 1-2 MAC was given for maintenance of anesthesia. Mechanical ventilation was adjusted to maintain an end-tidal CO2(ETCO2) between 35 and 40 mmHg. Toward the end of the procedure, neuromuscular blockade was reversed, followed by IV infusion of 15 mg/kg of paracetamol for postoperative pain relief. Sevoflurane was stopped upon spontaneous breathing with a regular pattern. Duration of surgery was measured from the skin incision until the last wound dressing had finished. Duration of anesthesia was measured from the time of induction until sevoflurane was stopped. Children in the propofol group received a bolus propofol in a dose of 0.5 mg/kg IV, while the control group did not receive any medication. The administration of propofol was performed by the OR team depending on the randomization.
Removal of the supraglottic airway device was done after the child was able to open eyes spontaneously and had regular spontaneous breathing. The child was then transported to the recovery room for observation. The transport time was measured from the cessation of sevoflurane until the child fulfills the transfer criteria to the recovery room. The transfer criteria included clear and patent airway without any maneuver, adequate ventilation and oxygenation, and hemodynamic stability. The child was monitored using a pulse oximeter during the transport to the recovery room.
Upon arrival and up to 30 min of care in the recovery room, the research team blinded to the allocation of the patients, conducted assessment of EA. EA was first screened using the Aono scale. Patients with Aono scale of ≥3 was then reassessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale, while patients with a score of <3 in the Aono scale was not reassessed with the PAED scale and recorded as non-EA. A diagnosis of EA was determined when a score of ≥3 in the Aono scale and ≥10 on the PAED scale was obtained. Children with a PAED score of ≥16 were considered to have severe EA and were administered a propofol bolus of 1 mg/kg for treatment of severe EA. Any hypotension in the PACU was treated with 20 mL/kg of intravenous crystalloid solution. In accordance with the Pediatric Advanced Life Support guidelines, hypotension was defined as systolic blood pressure <70+ (2 × age in years) mmHg. Ephedrine 0.1 mg/kg was given in cases where fluid resuscitation was not sufficient. In cases of desaturation, airway maneuver of chin lift or jaw thrust was performed and bag-mask-valve ventilation given with oxygen. Desaturation was defined as oxygen saturation less than 92% using standard equipment. Cases of hypotension, desaturation, and postoperative nausea-vomiting were recorded. Patients were monitored in the recovery room for 60 min and discharged to the ward once they obtained an Aldrete score ≥9 and did not have any agitation or vomiting. In the recovery room, all children were accompanied by their guardians. Cases of perioperative emergencies were handled in accordance to set guidelines and algorithms and were dropped out of the study.
Data acquired was then analyzed using the Statistical Package for Social Scientist (SPSS). Analysis of the proportion of EA was done using Chi-square, while the difference of transport time was analyzed using the unpaired t-test for normally distributed data and Mann–Whitney for not normally distributed data. Statistical analysis was determined to be significant when P < 0.05.
| Results|| |
A total of 108 children were included in this study, with 54 children in each group. The demographic data, duration of surgery and anesthesia, fentanyl use, and preanesthesia behavior score are shown in [Table 1].
The incidence of EA was observed to be significantly lower in the propofol group compared to that in the control group (25.9% vs. 51.9%). RR = 0.5, CI 95% = 0.298–0.840, P = 0.006.
The average transport time was significantly longer in the propofol group compared to the control group (9.5 ± 3.9 vs. 7.8 ± 3.5 min, mean difference 1.7 min [0.3–3.1]).
Hypotension was found in one case (1.9%) in the propofol group, while none was observed in the control group. Nausea-vomiting was observed more in the control group (14.8%) in comparison to the propofol group (9.3%). There were no observed cases of desaturation in either group. Additional propofol was not administered to any subjects.
| Discussion|| |
Incidence of EA varies greatly between 10% and 80%., An earlier study in our institution observed the incidence of EA in children undergoing inhalational anesthesia as 39.7%. We found the incidence of EA of 42 (38.9%) in the control group, which was similar to the previous study. We also observed that the incidence of EA in the propofol group was significantly less in comparison to the control group.
Administration of propofol in the dose of 1 mg/kg at the end of sevoflurane anesthesia to reduce incidence of EA was first reported by Aouad et al. in children undergoing strabismus procedure. Children who received propofol had an incidence of EA of 19.5% compared to 47.2% in the control group. Costi et al. reported similar results for children undergoing MRI. Two meta-analyses have shown that administration of propofol in the dose range of 1–3 mg/kg was effective in reducing the incidence and severity of EA in children without affecting recovery time and time of care in the PACU., Results from the present study indicate that a lower dose of 0.5 mg/kg of propofol exhibits a similar response in reducing the incidence of EA.
The mechanism of propofol in prevention of EA is still unclear. Sevoflurane is known to have a biphasic effect, which contributes to the clinical appearance of EA. The biphasic effect of sevoflurane potentiates postsynaptic inhibition by GABAA at high concentrations and blocks the inhibition at lower concentrations. Low concentrations of sevoflurane block inhibition of GABAA, hence causing a dominance in excitation synapses, presenting with agitation during emergence. Propofol given at the end of inhalational anesthesia acts as a sedative during the clearing process of sevoflurane to suppress the excitation synapses to prevent agitation during emergence. Propofol also reduces the hangover effect and provides an antiemetic effect that may be linked to the lower incidence of EA.,,
Pain may elicit agitation that presents as EA; however, EA also occurs in painless procedures. Hence, it is thought that pain is not the main cause of EA and administration of opioids for operative analgesic does not guarantee a lower incidence of EA.,, In this study, the incidence of pain varies due to the variety of procedures. Ideally, to reduce bias from pain and type of procedure toward the incidence of EA, the procedure type should have been uniform. However, to translate study results to a wider population and simplify the recruitment process, the authors decided to include a variety of procedure types. In order to reduce possible bias, randomization was done and the use of the PAED scale was performed to objectively differentiate pain from EA.
The difference in surgery and anesthesia time between the two groups is thought to be a source of bias toward the difference in EA incidence. However, studies by Singh et al. and Voepel-Lewis et al. observed that surgery and anesthesia time does not affect incidence of EA., Hence, it is assumed that the difference between surgery and anesthesia time did not affect the incidence of EA between the two groups.
Physiological conditions such as hypoxemia, hypercapnia, sepsis, hypoglycemia, hypotension, elevated intracranial pressure, and electrolyte imbalance are thought to be confounding factors. Through an extensive inclusion and exclusion criteria, the study population is thought to be physiologically normal preoperatively. Significant physiologic changes during anesthesia is an emergency condition and a dropout criterion.
The mean transport time in the propofol group was significantly higher in comparison to the control group. Several studies have shown that although propofol is effective in reducing the incidence of EA, it was related to an increase in time to extubation, time to transport to PACU, and return to consciousness.,,,, A study by Makkar et al. in children undergoing infraumbilical surgery observed similar results to the ones found in this study. The administration of propofol after inhalational anesthesia is thought to reduce EA through its sedative effect; however, it also prolongs the time needed for emergence.,
Time to emergence is known to be positively correlated with the duration of anesthesia. In the propofol group, the duration of surgery and anesthesia was observed to be longer than the control group. This prolonged duration may, in fact, contribute to the long transport time observed in the propofol group. There is a lack of the literature in regards to the minimum difference in surgery or anesthesia time that significantly affects time to emergence. A time of emergence above 30 min or known as delayed emergence is known to significantly affect morbidity. Hence, although statistically significant, the 1.7 min time difference observed in this study is thought to be not clinically significant.
There was only one case of hypotension and none of desaturation in the propofol group. This shows that propofol 0.5 mg/kg at the end of inhalation anesthesia does not pose a significant risk factor for postoperative hypotension and desaturation. The results seen in this study are in accordance to a meta-analysis conducted by Van Hoff et al. in where there was no significant difference between propofol and control group for cases of desaturation and hypotension. Hypotension and desaturation due to propofol are attributed more to induction dose or patients with hypovolemia and cardiovascular or respiratory compromised.
The incidence of nausea-vomiting was found to be lower in the propofol group in comparison to the control group. Sub-hypnotic propofol doses are known to have an antiemetic event, possibly attributed to propofol's mechanism of action as a dopamine receptor antagonist and serotonin antagonist.
In this study, the efficacy of propofol was based on the incidence of EA and transport time. Propofol 0.5 mg/kg was determined to be effective if it was able to lower the incidence of EA without significantly increasing transport time. This study showed a lower incidence of EA, but a longer transport time. However, the difference in transport time between the groups was only 1.7 min, providing little to no clinical significance. Hence, propofol 0.5 mg/kg was found clinically effective in reducing the incidence of EA in children undergoing inhalational anesthesia.
One of the limitations faced in this study was the variety of procedure types. A variety of procedure types was a source of bias, affecting the surgery and anesthesia durations, possibly affecting the transport time. As a result of the variety of procedure types, the level of pain was also not fully controlled. Pain is known to be a risk factor for EA. In order to reduce the possible bias from pain, the PAED scale was used to differentiate pain with EA.
| Conclusion|| |
In conclusion, the use of propofol 0.5 mg/kg at the end of general anesthesia reduces the incidence of EA in children after inhalation anesthesia with sevoflurane.
This study was supported by Department of Anesthesiology and Intensive Care, Faculty of Medicine, Indonesia University/Ciptomangunkusumo Hospital.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Uezono S, Goto T, Terui K, Ichinose F, Ishguro Y, Nakata Y,et al
. Emergence agitation after sevoflurane versus propofol in pediatric patients. Anesth Analg 2000;91:563-6.
Van Hoff SL, O'Neill ES, Cohen LC, Collins BA. Does a prophylactic dose of propofol reduce emergence agitation in children receiving anesthesia? A systematic review and meta-analysis. Pediatr Anesth 2015;25:668-76.
Jiang S, Liu J, Li M, Ji W, Liang J. The efficacy of propofol on emergence agitation – A meta-analysis of randomized controlled trials. Acta Anaesthesiologica Scandinavica 2015;59:1232-45.
Aktara B. Emergence agitation
pascaoperatif pada pasien anak yang menjalani anestesia umum inhalasi di RSUPN Cipto Mangunkusumo. Kajian terhadap angka kejadian dan faktor-faktor yang memengaruhi (thesis). Jakarta: Universitas Indonesia; 2014.
Costi D, Ellwood J, Wallace A, Ahmed S, Waring L, Cyna A. Transition to propofol after sevoflurane anesthesia to prevent emergence agitation: A randomized controlled trial. Pediatr Anesth 2015;25:517-23.
Ali MA, Abdellatif AA. Prevention of sevoflurane related emergence agitation in children undergoing adenotonsillectomy: A comparison of dexmedetomidine and propofol. Saudi J Anaesth 2013;7:296-300.
Makkar JK, Bhatia N, Bala I, Dwivedi D, Singh PM. A comparison of single dose dexmedetomidine with propofol for the prevention of emergence delirium after desflurane anesthesia in children. Anesthesia 2016;71:50-7.
Beringer RM, Greenwood R, Kilpatrick N. Development and validation of the Pediatric Anesthesia Behavior score – An objective measure of behavior during induction of anesthesia. Pediatr Anesth 2014;24:196-200.
Aono J, Ueda W, Mamiya K, Takimoto E, Manabe M. Greater incidence of delirium during recovery from sevoflurane anesthesia in preschool boys. Anesthesiology 1997;87:1298-300.
Aouad MT, Yazbeck-Karam VG, Nasr VG, El-Khatib MF, Kanazi GE, Bleik JH. A single dose of propofol at the end of surgery for the prevention of emergence agitation in children undergoing strabismus surgery during sevoflurane anesthesia. Anesthesiology 2007;107:733-8.
Somaini M, Ingelmo PM. Negative behaviour after surgery. In: Astuto M, Ingelmo PM, editors. Perioperative Medicine in Pediatric Anesthesia. Switzerland: Springer International Publishing; 2016. p. 408-10.
Liu GY, Chen ZQ, Zhang ZW. Comparative study of emergence agitation between isoflurane and propofol anesthesia in adults after closed reduction of distal radius fracture. Genet Mol Res 2014;13:9285-91.
Moore AD, Anghelescu DL. Emergence delirium in pediatric anesthesia. Pediatr Drugs 2017;19:11-20.
Kanaya A, Kuratani N, Satoh D, Kurosawa S. Lower incidence of emergence agitation in children after propofol anesthesia compared with sevoflurane: A meta-analysis of randomized controlled trials. J Anesth 2014;28:4-11.
Da Silva LM, Braz LG, Modolo NSP. Emergence agitation in pediatric anesthesia: Current features. J Pediatr (Rio J) 2008;84:107-13.
Singh R, Kharbanda M, Sood N, Mahajan V, Chatterji C. Comparative evaluation of incidence of emergence agitation and post-operative recovery profile in pediatric patients after isoflurane, sevoflurane and desflurane anesthesia. Indian J Anaesth 2012;56:156-61.
] [Full text]
Voepel-Lewis T, Malviya S, Tait AR. A prospective cohort study of emergence agitation in the pediatric post anesthesia care unit. Anesth Analg 2003;96:1625-30.
Nicholau D, Haehn M. Postanesthesia recovery. In: Pardo MC Jr, Miller RD, editors. Basics of Anesthesia. 7th
ed. Philadelphia: Elsevier; 2018. p. 675-86.
Dahmani S, Stany I, Brasher C, Lejeune C, Bruneau B, Wood C, et al
. Pharmacological prevention of sevoflurane- and desflurane-related emergence agitation in children: A meta-analysis of published studies. Br J Anaesth 2010;104:216-23.
Misal US, Joshi SA, Shaikh MM. Delayed recovery from anesthesia: A postgraduate educational review. Anesth Essays Res 2016;10:164-72.
] [Full text]
Zhou J, Heitz JW. Delayed emergence. In: Heitz JW, editor. Post-Anesthesia Care: Symptoms, Diagnosis, and Management. Cambridge (UK): Cambridge University Press; 2016. p. 205-11.
Kawano H, Ohshita N, Katome K, Kadota T, Kinoshita M, Matsuoka Y. Effects of a novel method of anesthesia combining propofol and volatile anesthesia on the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic gynecological surgery. Braz J Anesthesiol 2016;66:12-8.